1,755
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Potential Biomarkers for Antidiastole of Tuberculous and Malignant Pleural Effusion By Proteome Analysis

, , , , , , , , , & show all
Pages 123-133 | Received 07 Jun 2018, Accepted 04 Dec 2018, Published online: 22 Feb 2019

References

  • Vorster MJ , AllwoodBW, DiaconAH, KoegelenbergCF. Tuberculous pleural effusions: advances and controversies. J. Thorac. Dis.7 (6), 981–991 (2015).
  • Porcel JM . Tuberculous pleural effusion. Lung187 (5), 263–270 (2009).
  • World Health Organization . Global tuberculosis report 2016. http://www.tbonline.info/posts/2016/10/16/global-tb-report-2016/.
  • Diacon AH , Van De WalBW, WyserCet al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur. Respir. J.22 (4), 589–591 (2003).
  • Light RW . Update on tuberculous pleural effusion. Respirology15 (3), 451–458 (2010).
  • Koegelenberg CF , BolligerCT, TheronJet al. Direct comparison of the diagnostic yield of ultrasound-assisted Abrams and Tru-Cut needle biopsies for pleural tuberculosis. Thorax65 (10), 857–862 (2010).
  • Valdes L , San-JoseE, FerreiroLet al. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients. Clin. Respir. J.9 (2), 203–213 (2015).
  • Yildirim H , MetintasM, AkGet al. Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome. Lung185 (6), 349–354 (2007).
  • Terra RM , AntonangeloL, MarianiAW, De OliveiraRL, TeixeiraLR, Pego-FernandesPM. Pleural fluid adenosine deaminase (ADA) predicts survival in patients with malignant pleural effusion. Lung194 (4), 681–686 (2016).
  • Yang Y , MuJ, ChenGet al. iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid reveals NELL2 as a potential diagnostic biomarker of tuberculous meningitis. Int. J. Mol. Med.35 (5), 1323–1332 (2015).
  • Ding Y , YangM, SheSet al. iTRAQ-based quantitative proteomic analysis of cervical cancer. Int. J. Oncol.46 (4), 1748–1758 (2015).
  • WHO . Treatment of tuberculosis guidelines for national programmes (2015). http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codcch=4397.
  • Thurnher MM . 2007 World Health Organization classification of tumours of the central nervous system. Cancer Imaging9 (Spec No A), S1–S3 (2009).
  • WHO . Treatment guidelines for drug-resistant tuberculosis (2016). https://www.who.int/tb/areas-of-work/drug-resistant-tb/treatment/resources/en/.
  • Hanley JA , McneilBJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology148 (3), 839–843 (1983).
  • Zeng N , WanC, QinJet al. Diagnostic value of interleukins for tuberculous pleural effusion: a systematic review and meta-analysis. BMC Pulm. Med.17 (1), 180 (2017).
  • Ferreiro L , San JoseE, ValdesL. Tuberculous pleural effusion. Arch. Bronconeumol.50 (10), 435–443 (2014).
  • Rodriguez-Panadero F , Romero-RomeroB. Management of malignant pleural effusions. Curr. Opin. Pulm. Med.17 (4), 269–273 (2011).
  • Simpson G , JudgeDJ. Management of malignant pleural effusion. Respirology20 (1), 169 (2015).
  • Srour N , AmjadiK, ForsterA, AaronS. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis. Can. Respir. J.20 (2), 106–110 (2013).
  • Gopi A , MadhavanSM, SharmaSK, SahnSA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest131 (3), 880–889 (2007).
  • Valdes L , FerreiroL, Cruz-FerroEet al. Recent epidemiological trends in tuberculous pleural effusion in Galicia, Spain. Eur. J. Intern. Med.23 (8), 727–732 (2012).
  • Ruan SY , ChuangYC, WangJYet al. Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax67 (9), 822–827 (2012).
  • Qiu L , TeeterLD, LiuZet al. Diagnostic associations between pleural and pulmonary tuberculosis. J. Inf. Secur.53 (6), 377–386 (2006).
  • Liang QL , ShiHZ, WangK, QinSM, QinXJ. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir. Med.102 (5), 744–754 (2008).
  • Yurt S , KucukerginC, YigitbasBA, SeckinS, TiginHC, KosarAF. Diagnostic utility of serum and pleural levels of adenosine deaminase 1–2, and interferon-gamma in the diagnosis of pleural tuberculosis. Multidiscip. Respir. Med.9 (1), 12 (2014).
  • Dheda K , Van Zyl-SmitRN, SechiLAet al. Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis. Eur. Respir. J.34 (5), 1118–1126 (2009).
  • Heffner JE , KleinJS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo. Clin. Proc.83 (2), 235–250 (2008).
  • Moro-Sibilot D , SmitE, De Castro CarpenoJet al. Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. Lung Cancer88 (2), 215–222 (2015).
  • Yu CJ , WangCL, WangCIet al. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J. Proteome Res.10 (10), 4671–4682 (2011).
  • Sallach SM , SallachJA, VasquezE, SchultzL, KvaleP. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest122 (6), 1913–1917 (2002).
  • Domej W , TilzGP, Földes-PappZet al. Cystatin C of pleural effusion as a novel diagnostic aid inpleural diseases of different aetiologies. Clin. Sci. (London)102 (3), 373–380 (2002).
  • Malik G , KnowlesLM, DhirRet al. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res.70 (11), 4327–4334 (2010).
  • Pankov R , YamadaKM. Fibronectin at a glance. J. Cell Sci.115 (20), 3861–3863 (2002).
  • Williams CM , EnglerAJ, SloneRD, GalanteLL, SchwarzbauerJE. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res.68 (9), 3185–3192 (2008).
  • Meena LS , MeenaJ. Cloning and characterization of a novel PE_PGRS60 protein (Rv3652) of Mycobacterium tuberculosis H37 Rv exhibit fibronectin-binding property. Biotechnol. Appl. Biochem.63 (4), 525–531 (2016).
  • De Oliveira EO , WangK, KongHSet al. Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema. Bioorg. Med. Chem. Lett.21 (22), 6746–6750 (2011).
  • Xiao Q , DongN, YaoXet al. Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H. Sci. Rep.6, 25298 (2016).
  • Snelgrove RJ , JacksonPL, HardisonMTet al. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science330 (6000), 90–94 (2010).
  • Okudela K , MitsuiH, WooTet al. Alterations in cathepsin L expression in lung cancers. Pathol. Int.66 (7), 386–392 (2016).
  • Hamon Y , LegowskaM, HerveVet al. Neutrophilic cathepsin c is maturated by a multistep proteolytic process and secreted by activated cells during inflammatory lung diseases. J. Biol. Chem.291 (16), 8486–8499 (2016).
  • Steinwede K , MausR, BohlingJet al. Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice. J. Immunol.188 (9), 4476–4487 (2012).
  • Rivera-Marrero CA , StewartJ, ShaferWM, RomanJ. The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli. Infect. Immun.72 (10), 5712–5721 (2004).